关键词: Acalasia Achalasia Botulinum toxin Dilatación neumática Disfagia persistente Disfagia recurrente Eckardt score Esofagectomia Esophageal manometry Esophagectomy Laparoscopic Heller myotomy Manometria esofágica Miotomía laparoscópica de Heller POEM Persistent dysphagia Pneumatic dilatation Recurrent dysphagia Toxina botulínica Índice Eckardt

Mesh : Esophageal Achalasia / therapy surgery diagnosis Humans Time Factors

来  源:   DOI:10.1016/j.cireng.2024.04.001

Abstract:
Over the last few decades, significant improvement has been made in both the evaluation and treatment of esophageal achalasia. The Chicago classification, today in version 4.0, is now the standard for diagnosis of achalasia, providing a classification into 3 subtypes with important therapeutic and prognostic implications. Therapy, which was at first mostly limited to pneumatic dilatation, today includes minimally invasive surgery and peroral endoscopic myotomy, allowing for a more tailored approach to patients and better treatment of recurrent symptoms. This review chronicles my personal experience with achalasia over the last 35 years, describing the progress made in the treatment of patients with achalasia.
摘要:
在过去的几十年里,食管贲门失弛缓症的评估和治疗均有显著改善。芝加哥分类,今天在4.0版本中,现在是诊断贲门失弛缓症的标准,提供了3个亚型的分类,具有重要的治疗和预后意义。Therapy,起初主要限于气动扩张,今天包括微创手术和经口内镜肌切开术,允许为患者提供更量身定制的方法,并更好地治疗复发症状。这篇评论记录了我在过去35年中对贲门失弛缓症的个人经历,描述贲门失弛缓症患者的治疗进展。
公众号